From Paper to Planet: Embracing Digital Quality Systems

For Earth Day 2026, we wanted to discuss a decision that life sciences companies often make, and that is to continue with paper-intensive operations or transition to digital solutions like electronic quality management systems (eQMS) and electronic batch records (EBR). For these companies, digital transformation is not just an environmentally conscious choice but could also lead to financial benefits.

The Hidden Environmental Cost of Paper

The pharmaceutical industry remains one of the most paper-intensive sectors globally. Each production batch generates extensive documentation including manufacturing records, quality control tests and checks, quality event logs, and various approvals. For large manufacturers and CDMOs, this translates into millions of printed pages annually.

There is an environmental cost to this paper usage; per the UK government’s conversion factor, 200,000 sheets of office paper consume 7,000 gallons of water and generate one metric ton of carbon equivalent greenhouse gas emissions. Considering that the average office worker can use up to 10,000 sheets of copy paper each year, this routine operation can release large amounts for a mid-sized life sciences manufacturer For global enterprises operating multiple facilities, these figures escalate dramatically when factoring in transportation, storage, archiving, and the inevitable waste from misprints and documentation errors.

Digital Transformation: Measurable Sustainability Gains

EBRs and eQMS, by their digital design, are able to eliminate the environmental burdens of traditional paper-based processes. By digitizing batch documentation and quality workflows, companies can significantly reduce their reliance on physical paperwork. In practice, organizations have reported consolidating paper-based records—each potentially hundreds of pages long—into streamlined digital formats, cutting down on printing, storage, and manual data entry. DKSH reduced paper usage by 53% in 2024 just in their first phase of ACE implementation.

Industry-wide trends reflect this shift. In recent years, a growing number of life sciences and biotech companies have cited environmental sustainability as a key driver for adopting EBRs. Many report substantial reductions in paper usage alongside lower energy consumption tied to documentation and recordkeeping. In some cases, digital systems have enabled up to 90% reductions in paper use, translating directly into a smaller carbon footprint. Additionally, batch records that once required thousands of manual entries can now be automated, reducing errors and further improving operations.

The Financial Case: ROI Beyond Sustainability

Environmental benefits tell only part of the story. Digital systems deliver compelling financial returns through operational efficiency gains:

• Faster batch review: Electronic systems reduce review cycles compared to paper processes
• Error reduction: Digital workflows can help eliminate data entry errors
• Storage savings: Elimination of physical archives reduces real estate costs and document retrieval time
• Hardware consolidation: Phasing out redundant scanners, printers, and servers cuts both e-waste and energy consumption

Regulatory Momentum Supports Digital Adoption

From a compliance perspective, the shift toward electronic documentation aligns perfectly with evolving regulatory expectations. While not mandatory, the FDA and EMA have both recognized that electronic documentation is now industry standard, and can help to ensure data integrity, real-time traceability, and audit readiness.

EBRs and eQMS meet these criteria by providing audit trails, time-stamped approvals, and secure storage, capabilities that reduce the risk of incomplete or lost records while improving inspection readiness. According to the 2023 ISPE Pharma 4.0 Survey, the proportion of companies engaged in digital “pilots” or “systematic ongoing actions” rose to 58.1%, with 50% of manufacturing and engineering respondents identifying EBRs as a main focus area.

The Path Forward

The transition to eQMS and EBR represents a strategic investment in environmental stewardship, operational excellence, and regulatory alignment. With paper reduction, efficiency gains, and measurable ROI, the business case is clear.

The life sciences companies that embrace digital quality systems today will lead tomorrow’s sustainable, efficient, and compliant manufacturing landscape. The question now is not whether to go digital, but how quickly and effectively companies can make the transition. If this is a question that interests you and your company, contact PSC Software today and we can find an answer together.